Detalhe da pesquisa
1.
Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.
Am J Hematol
; 96(10): 1241-1252, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34265103
2.
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
Blood
; 132(20): 2115-2124, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30181172
3.
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.
Blood
; 129(12): 1646-1657, 2017 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28087540
4.
A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease.
Mod Rheumatol
; 29(2): 302-305, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30285516
5.
IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review.
Mod Rheumatol
; 29(2): 258-267, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30427250
6.
Tentative diagnostic criteria and disease severity classification for Castleman disease: A report of the research group on Castleman disease in Japan.
Mod Rheumatol
; 28(1): 161-167, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28880697
7.
Prediction and experimental validation of a putative non-consensus binding site for transcription factor STAT3 in serum amyloid A gene promoter.
Biochim Biophys Acta
; 1830(6): 3650-5, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23391827
8.
Immunology and targeted therapy in Castleman disease.
Expert Rev Clin Immunol
; : 1-12, 2024 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38785062
9.
Predictive biomarkers of COVID-19 prognosis identified in Bangladesh patients and validated in Japanese cohorts.
Sci Rep
; 14(1): 12713, 2024 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38830928
10.
Peripheral helper-T-cell-derived CXCL13 is a crucial pathogenic factor in idiopathic multicentric Castleman disease.
Nat Commun
; 14(1): 6959, 2023 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37907518
11.
Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease.
Blood
; 116(18): 3627-34, 2010 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20644113
12.
A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
Mod Rheumatol
; 22(2): 298-302, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21748365
13.
A reference guide for management of Castleman disease.
Rinsho Ketsueki
; 58(2): 97-107, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-28321096
14.
Anti-nucleocapsid antibodies enhance the production of IL-6 induced by SARS-CoV-2 N protein.
Sci Rep
; 12(1): 8108, 2022 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577892
15.
Prompt Reduction in CRP, IL-6, IFN-γ, IP-10, and MCP-1 and a Relatively Low Basal Ratio of Ferritin/CRP Is Possibly Associated With the Efficacy of Tocilizumab Monotherapy in Severely to Critically Ill Patients With COVID-19.
Front Med (Lausanne)
; 8: 734838, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34631752
16.
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.
Blood Adv
; 4(23): 6039-6050, 2020 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33284946
17.
[New therapeutic strategy for autoimmune and chronic inflammatory disease based on clinical results using IL-6 blocking therapy with a humanized anti-IL-6 receptor antibody].
Yakugaku Zasshi
; 129(6): 667-74, 2009 Jun.
Artigo
em Japonês
| MEDLINE | ID: mdl-19483409
18.
The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.
J Clin Invest
; 115(2): 313-25, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15668741
19.
The Role of Interleukin-6 in Castleman Disease.
Hematol Oncol Clin North Am
; 32(1): 23-36, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29157617
20.
Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease.
Haematologica
; 92(6): 857-8, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17550864